In this study, analogues of olomoucine, a previously described plant cytokinin analogue with cyclin-dependent kinase (CDK) inhibitory activity, were investigated for effect on CDK1 and CDK2 and for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results